|
|
||||||||
Clinical Chemistry, Vol 36, 1951-1955, Copyright © 1990 by American Association for Clinical Chemistry
TG Rosano, RT Ambrose, AH Wu, TA Swift and P Yadegari
Department of Pathology and Laboratory Medicine, Albany Medical Center, NY 12208.
We describe a "high-performance" liquid chromatographic (HPLC) method for accurately determining creatinine in serum. After prechromatographic precipitation of protein, we performed isocratic ion- exchange chromatography with ultraviolet detection (234 nm). Analytical results showed linearity up to 1770 mumol/L, a detection limit of 22 mumol/L, an average analytical recovery of 101%, and a CV ranging from 3% to 11%. We used certified human serum (National Institute of Standards and Technology), and additional lyophilized serum pools also assayed by definitive isotope-dilution mass spectrometry, to validate the accuracy of the HPLC method. In addition, the isocratic HPLC results showed close agreement with those obtained with a step-gradient HPLC method. We also compared the isocratic HPLC method with alkaline picrate and enzymatic methods. Our findings with samples from nonuremic, uremic, and diabetic ketoacidotic patients confirmed the positive bias previously reported with the alkaline picrate method. Interlaboratory transferability of the method was demonstrated with various commercial instruments and analytical columns. We evaluated column stability and possible interference from endogenous or exogenous compounds. On the basis of our analytical findings, we recommend the isocratic HPLC method as a candidate Reference Method for determining creatinine in serum.
The following articles in journals at HighWire Press have cited this article:
![]() |
R. J. Hogg, L. Fitzgibbons, C. Atkins, N. Nardelli, R. C. Bay, and for the North American IgA Nephropathy Study Group Efficacy of Omega-3 Fatty Acids in Children and Adults with IgA Nephropathy Is Dosage- and Size-Dependent Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1167 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hogg, J. Lee, N. Nardelli, B. A. Julian, D. Cattran, B. Waldo, R. Wyatt, J. C. Jennette, R. Sibley, K. Hyland, et al. Clinical Trial to Evaluate Omega-3 Fatty Acids and Alternate Day Prednisone in Patients with IgA Nephropathy: Report from the Southwest Pediatric Nephrology Study Group Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 467 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E Nix, B. L Erstad, P. Z Nakazato, J. F Barletta, K. R Matthias, and T. S Krueger Estimation of Creatinine Clearance in End-Stage Liver Disease Ann. Pharmacother., May 1, 2006; 40(5): 900 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Myers, W. G. Miller, J. Coresh, J. Fleming, N. Greenberg, T. Greene, T. Hostetter, A. S. Levey, M. Panteghini, M. Welch, et al. Recommendations for Improving Serum Creatinine Measurement: A Report from the Laboratory Working Group of the National Kidney Disease Education Program Clin. Chem., January 1, 2006; 52(1): 5 - 18. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |